Stocks and Investing Stocks and Investing
Wed, January 5, 2022
[ 12:00 AM ] - WOPRAI
Robert Simmons Initiated (ASAN) at Hold and Held Target at $65 on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Toni Kaplan Maintained (ARMK) at Hold with Increased Target to $40 on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Vamil Divan Maintained (ABBV) at Strong Buy with Increased Target to $154 on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Amit Daryanani Maintained (AAPL) at Buy and Held Target at $200 on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Zachary Fadem Maintained (AAP) at Hold with Increased Target to $255 on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Mark Miller Maintained (ACMR) at Strong Buy with Increased Target to $43 on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Neena Bitritto-Garg Upgraded (ACAD) to Strong Buy and Held Target at $30 on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Savanthi Syth Downgraded (ALGT) to Hold on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Leo Mariani Initiated (BE) at Buy and Held Target at $30 on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Debjit Chattopadhyay Initiated (BEAM) at Strong Buy and Held Target at $130 on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Zachary Fadem Maintained (BBY) at Hold with Decreased Target to $110 on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Thomas Gallagher Downgraded (BHF) to Hold and Decreased Target to $57 on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Toni Kaplan Maintained (BFAM) at Sell with Decreased Target to $109 on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Jim Mitchell Maintained (BK) at Strong Buy with Increased Target to $72 on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Leo Mariani Initiated (BLDP) at Hold on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Roger Read Downgraded (BP) to Sell on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Gregg Orrill Downgraded (AWK) to Strong Sell and Decreased Target to $176 on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Ross Seymore Maintained (AMBA) at Hold with Increased Target to $175 on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Geoff Meacham Downgraded (AMGN) to Hold and Decreased Target to $255 on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
James Rutherford Upgraded (CAKE) to Buy and Decreased Target to $47 on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
David Katz Initiated (CCL) at Hold and Held Target at $24 on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Philip Cusick Downgraded (CCI) to Hold on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Toni Kaplan Maintained (SPGI) at Buy with Increased Target to $526 on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Joseph Altobello Maintained (SMG) at Strong Buy with Decreased Target to $195 on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Robert Simmons Initiated (SMAR) at Strong Buy and Held Target at $100 on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Tom Hughes Upgraded (SM) to Buy and Held Target at $42 on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Philip Shen Upgraded (SOL) to Strong Buy and Increased Target to $10 on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Gabriel Moreen Downgraded (SR) to Hold and Held Target at $68 on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Toni Kaplan Upgraded (STER) to Buy and Decreased Target to $25 on, Jan 5th, 2022
[ 12:00 AM ] - WOPRAI
Gil Blum Maintained (SRPT) at Strong Buy with Decreased Target to $150 on, Jan 5th, 2022

Gil Blum Maintained (SRPT) at Strong Buy with Decreased Target to $150 on, Jan 5th, 2022


Published on 2024-10-27 19:08:33 - WOPRAI, Gil Blum
  Print publication without navigation


Gil Blum of Needham, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Strong Buy with Decreased Target from $157 to $150 on, Jan 5th, 2022.

Gil has made no other calls on SRPT in the last 4 months.



There are 6 other peers that have a rating on SRPT. Out of the 6 peers that are also analyzing SRPT, 1 agrees with Gil's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Judah Frommer of "Credit Suisse" Maintained at Hold with Decreased Target to $95 on, Friday, October 15th, 2021


These are the ratings of the 5 analyists that currently disagree with Gil

  • Hartaj Singh of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $125 on, Thursday, December 9th, 2021
  • Anupam Rama of "JP Morgan" Upgraded from Hold to Buy and Increased Target to $130 on, Friday, November 5th, 2021
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Decreased Target to $145 on, Thursday, November 4th, 2021
  • Yun Zhong of "BTIG" Maintained at Strong Buy with Increased Target to $125 on, Tuesday, October 12th, 2021
  • Whitney Ijem of "Guggenheim" Upgraded from Hold to Strong Buy on, Wednesday, September 15th, 2021
Contributing Sources